Science Explorer Back to mapMap
Discussion
Company · Lysaker · Norway

PCI Biotech (Norway)

pcibiotech.comROR OpenAlex
Research works
58
▼ 43% vs 2018-21
Citations
1.9k
33.4 per fractional work
Top-10% rate
0.0%
all institutions 10.0%
Open access
19%
world 40%
International
38%
world 18%
PCI Biotech (Norway)

Not ranked overall: PCI Biotech (Norway) is under the volume floor below which an excellence rate is noise. Not ranked is not the same as ranked last.

Which fields of science does PCI Biotech (Norway) work in?

In all years, 44% of research at PCI Biotech (Norway) is in Life Sciences, 35% in Physical Sciences. Its largest fields are Biochemistry, Genetics and Molecular Biology (34%), Medicine (21%), Engineering (13%). It does 2.4× the world's share of Life Sciences.

Life Sciences: 25 fractional works · 43.6% of its workBiochemistry, Genetics and Molecular Biology: 20 fractional works · 34.4% of its workMolecular Biology: 14 fractional works · 23.9% of its workGenetics: 4 fractional works · 6.4% of its workBiotechnology: 2 fractional works · 2.9% of its workCancer Research: 0 fractional works · 0.7% of its workSmaller subfields together: 0 fractional works · 0.5% of its workImmunology and Microbiology: 5 fractional works · 7.9% of its workImmunology: 4 fractional works · 7.3% of its workMicrobiology: 0 fractional works · 0.4% of its workVirology: 0 fractional works · 0.2% of its workAgricultural and Biological Sciences: 1 fractional works · 1.1% of its workPlant Science: 0 fractional works · 0.8% of its workGeneral Agricultural and Biological Sciences: 0 fractional works · 0.3% of its workPharmacology, Toxicology and Pharmaceutics: 0 fractional works · 0.1% of its workPhysical Sciences: 20 fractional works · 34.5% of its workEngineering: 7 fractional works · 12.8% of its workBiomedical Engineering: 6 fractional works · 10.9% of its workControl and Systems Engineering: 0 fractional works · 0.6% of its workIndustrial and Manufacturing Engineering: 0 fractional works · 0.6% of its workMechanical Engineering: 0 fractional works · 0.6% of its workSmaller subfields together: 0 fractional works · 0.2% of its workMaterials Science: 4 fractional works · 7.5% of its workMaterials Chemistry: 3 fractional works · 4.7% of its workBiomaterials: 1 fractional works · 1.7% of its workPolymers and Plastics: 0 fractional works · 0.9% of its workSmaller subfields together: 0 fractional works · 0.2% of its workChemistry: 4 fractional works · 7.4% of its workSpectroscopy: 2 fractional works · 3.1% of its workOrganic Chemistry: 2 fractional works · 2.6% of its workAnalytical Chemistry: 1 fractional works · 1.2% of its workPhysical and Theoretical Chemistry: 0 fractional works · 0.6% of its workEnvironmental Science: 2 fractional works · 3.1% of its workEcology: 1 fractional works · 1.4% of its workNature and Landscape Conservation: 1 fractional works · 1.1% of its workIndustrial and Manufacturing Engineering: 0 fractional works · 0.3% of its workSmaller subfields together: 0 fractional works · 0.4% of its workComputer Science: 1 fractional works · 2.0% of its workArtificial Intelligence: 0 fractional works · 0.9% of its workInformation Systems: 0 fractional works · 0.6% of its workComputational Theory and Mathematics: 0 fractional works · 0.3% of its workComputer Networks and Communications: 0 fractional works · 0.3% of its workEnergy: 0 fractional works · 0.9% of its workRenewable Energy, Sustainability and the Environment: 0 fractional works · 0.9% of its workEarth and Planetary Sciences: 0 fractional works · 0.6% of its workOceanography: 0 fractional works · 0.6% of its workMathematics: 0 fractional works · 0.3% of its workStatistics and Probability: 0 fractional works · 0.3% of its workHealth Sciences: 12 fractional works · 21.6% of its workMedicine: 12 fractional works · 20.8% of its workPulmonary and Respiratory Medicine: 6 fractional works · 11.1% of its workOncology: 2 fractional works · 2.6% of its workSurgery: 1 fractional works · 2.1% of its workRadiology, Nuclear Medicine and Imaging: 1 fractional works · 1.7% of its workDermatology: 1 fractional works · 1.0% of its workPublic Health, Environmental and Occupational Health: 0 fractional works · 0.4% of its workEpidemiology: 0 fractional works · 0.4% of its workPhysiology: 0 fractional works · 0.3% of its workReproductive Medicine: 0 fractional works · 0.3% of its workSmaller subfields together: 0 fractional works · 0.9% of its workHealth Professions: 0 fractional works · 0.6% of its workPharmacy: 0 fractional works · 0.6% of its workVeterinary: 0 fractional works · 0.1% of its workNursing: 0 fractional works · 0.1% of its workSocial Sciences: 0 fractional works · 0.3% of its workPsychology: 0 fractional works · 0.1% of its workSocial Sciences: 0 fractional works · 0.1% of its workALL ITS WORKPCI Biotech(Norway)58fractional works, all years
Life Sciences44%Physical Sciences35%Health Sciences22%Social Sciences0%

Each ring splits the one inside it: the four domains of science, their fields, their subfields. Size is fractional works in all years. Every slice is a page; the interactive view zooms down to single topics and colours each by how much more of it this institution does than the world.

Its 4 domains and 18 fields, with their numbers
    1. Biochemistry, Genetics and Molecular Biology2034.4%
    2. Immunology and Microbiology57.9%
    3. Agricultural and Biological Sciences11.1%
    4. Pharmacology, Toxicology and Pharmaceutics00.1%
    1. Engineering712.8%
    2. Materials Science47.5%
    3. Chemistry47.4%
    4. Environmental Science23.1%
    5. Computer Science12.0%
    6. Energy00.9%
    7. Earth and Planetary Sciences00.6%
    8. Mathematics00.3%
    1. Medicine1220.8%
    2. Health Professions00.6%
    3. Veterinary00.1%
    4. Nursing00.1%
    1. Psychology00.1%
    2. Social Sciences00.1%
All of science, and how each field's share has moved since 1950: the Science domain explorer

Field profile

Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.

Agricultural and Biological Sciences: 0.63× its world share, 0 worksAgricultural and Bio…Biochemistry, Genetics and Molecular Biology: 2.58× its world share, 0 worksBiochemistry, Geneti…Immunology and Microbiology: 6.68× its world share, 0 worksImmunology and Micro…Chemistry: 0.82× its world share, 0 worksChemistryEngineering: 1.69× its world share, 1 worksEngineeringMaterials Science: 3.94× its world share, 0 worksMaterials ScienceMedicine: 1.81× its world share, 1 worksMedicineNursing: 2.62× its world share, 0 worksNursing1×world share
more than its size predictsabout as predictedless

Rings at 0.5×, 1× and 2×. Widest outward: Immunology and Microbiology, 6.7×. Every wedge is a field page.

All 8 fields, with their numbers
  1. Immunology and Microbiology6.68×0 works
  2. Materials Science3.94×0 works
  3. Nursing2.62×0 works
  4. Biochemistry, Genetics and Molecular Biology2.58×0 works
  5. Medicine1.81×1 works
  6. Engineering1.69×1 works
  7. Chemistry0.82×0 works
  8. Agricultural and Biological Sciences0.63×0 works

Who are the top researchers at PCI Biotech (Norway)?

Ranked on the quality score, Anders Høgset and Monika Håkerud lead among researchers whose main affiliation is PCI Biotech (Norway).

  1. 1 Anders Høgset Norway · #1,960,416 worldwide 4.8k citations · 133 works
  2. 2 Monika Håkerud Norway · #4,007,088 worldwide 918 citations · 23 works
All ranked researchers at PCI Biotech (Norway)

What are the most cited papers from PCI Biotech (Norway)?

The most cited paper from PCI Biotech (Norway) is "Characterisation of Dynabeads® by magnetization measurements and Mössbauer spectroscopy" (Geir Fonnum, Christer Johansson, Astrid Molteberg et al., 2005), with 309 citations. Next come "Photochemical internalization provides time- and space-controlled endolysosomal escape of therapeutic molecules" (281) and "Porphyrin‐related photosensitizers for cancer imaging and therapeutic applications" (275).

Most cited papers
#PaperReleasedCitations
1 Characterisation of Dynabeads® by magnetization measurements and Mössbauer spectroscopy Geir Fonnum, Christer Johansson, Astrid Molteberg et al. · Journal of Magnetism and Magnetic Materials 13 Apr 2005 309
2 Photochemical internalization provides time- and space-controlled endolysosomal escape of therapeutic molecules Pål Kristian Selbo, Anette Weyergang, Anders Høgset et al. · Journal of Controlled Release 20 Jun 2010 281
3 Porphyrin‐related photosensitizers for cancer imaging and therapeutic applications Kristian Berg, Pål Kristian Selbo, Anette Weyergang et al. · Journal of Microscopy 27 Apr 2005 275
4 Photochemical internalisation in drug and gene delivery Anders Høgset · Advanced Drug Delivery Reviews 4 Dec 2003 224
5 Biodegradable Dextran Nanogels for RNA Interference: Focusing on Endosomal Escape and Intracellular siRNA Delivery Koen Raemdonck, Broes Naeye, Kevin Buyens et al. · Advanced Functional Materials 30 Mar 2009 144
All 62 most cited papers, with filters and sorting

Which keywords describe research at PCI Biotech (Norway)?

By fractional works in all years, weighted toward what it does more of than the world: Nanoparticles, Gene Therapy, Photodynamic Therapy, Reactive Oxygen Species, Cancer Treatment, Antimicrobial, Immunotherapy and Photosensitizers.

▲ more of its work than of the world's◆ about the world's share▼ less than the world's

Size is fractional works in all years in the topics tagged with each word; colour is the word's share of this institution's work against its share of the world's. The 40 words are chosen for being large and distinctive. Each links to the topic it comes from most.

All 40 words, with their numbers
  1. Nanoparticles12▲ 16×9 topics
  2. Gene Therapy10▲ 62×3 topics
  3. Photodynamic Therapy9▲ 102×3 topics
  4. Reactive Oxygen Species9▲ 32×4 topics
  5. Cancer Treatment6▲ 41×3 topics
  6. Antimicrobial6▲ 40×3 topics
  7. Immunotherapy6▲ 16×8 topics
  8. Photosensitizers6▲ 431×1 topic
  9. Singlet Oxygen6▲ 431×1 topic
  10. RNA Interference5▲ 78×1 topic
  11. Tumor Targeting5▲ 67×3 topics
  12. siRNA Delivery5▲ 117×1 topic
  13. Self-Assembly4▲ 17×4 topics
  14. Genomic Integration3▲ 56×2 topics
  15. Fluorescence Imaging3▲ 51×1 topic
  16. Photothermal Therapy3▲ 68×1 topic
  17. AAV3▲ 76×1 topic
  18. Viral Vectors3▲ 76×1 topic
  19. Biosensors3▲ 8.5×5 topics
  20. Antigen Presentation2▲ 41×2 topics
  21. Cancer Immunotherapy2▲ 30×2 topics
  22. Tumor Regression2▲ 41×2 topics
  23. Innate Immunity2▲ 9.9×2 topics
  24. DNA nanotechnology2▲ 31×1 topic
  25. Dendritic Cells2▲ 28×1 topic
  26. Immunity2▲ 9.5×1 topic
  27. aptamers2▲ 31×1 topic
  28. 3D Printing2▲ 16×2 topics
  29. Cancer Therapy2▲ 4.7×4 topics
  30. Lab-on-a-Chip2▲ 22×2 topics
  31. Point-of-Care Diagnostics2▲ 35×2 topics
  32. Drug Delivery2▲ 5.9×6 topics
  33. Arginine Deprivation2▲ 60×1 topic
  34. Bacterial Therapy2▲ 60×1 topic
  35. Glycosylation2▲ 12×3 topics
  36. Biomedical Research1▲ 33×1 topic
  37. Poly(dimethylsiloxane)1▲ 51×1 topic
  38. Genomic Stability1▲ 23×2 topics
  39. Phthalocyanines1▲ 48×1 topic
  40. Porphyrins1▲ 48×1 topic

Which research topics does PCI Biotech (Norway) publish most on?

By volume in 2022-now: Nanoplatforms for cancer theranostics, Ferroptosis and cancer prognosis, Photodynamic Therapy Research Studies and Bone Tissue Engineering Materials.

Nanoplatforms for cancer theranostics: 0 fractional worksFerroptosis and cancer prognosis: 0 fractional worksPhotodynamic Therapy Res…0Photodynamic Therapy Research Studies: 0 fractional worksBone Tissue Engineering …0Bone Tissue Engineering Materials: 0 fractional worksElectrospun Nanofibers i…0Electrospun Nanofibers in Biomedical Applications: 0 fractional worksTissue Engineering and R…0Tissue Engineering and Regenerative Medicine: 0 fractional worksbioluminescence and chemiluminescence research: 0 fractional worksCancer, Hypoxia, and Metabolism: 0 fractional worksEnzyme-mediated dye degradation: 0 fractional worksImmunotherapy and Immune Responses: 0 fractional works
Biomedical EngineeringPulmonary and Respiratory MedicineBiomaterialsSurgery4 others

Area is fractional works; colour is the subfield each topic belongs to.

  1. 1 Nanoplatforms for cancer theranostics Biomedical Engineering 0 works
  2. 2 Ferroptosis and cancer prognosis Pulmonary and Respiratory Medicine 0 works
  3. 3 Photodynamic Therapy Research Studies Pulmonary and Respiratory Medicine 0 works
  4. 4 Bone Tissue Engineering Materials Biomedical Engineering 0 works
  5. 5 Electrospun Nanofibers in Biomedical Applications Biomaterials 0 works
  6. 6 Tissue Engineering and Regenerative Medicine Surgery 0 works
  7. 7 bioluminescence and chemiluminescence research Molecular Biology 0 works
  8. 8 Cancer, Hypoxia, and Metabolism Cancer Research 0 works
  9. 9 Enzyme-mediated dye degradation Plant Science 0 works
  10. 10 Immunotherapy and Immune Responses Immunology 0 works

How open and international is its research?

Against the world's own shares: the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.

openly available18.7%not open81.3%

World: 40% of research is openly available.

with international co-authors37.6%domestic only62.4%

World: 18% is written across borders.

How has PCI Biotech (Norway)'s research output changed?

Output in 2022-2025 was 43% lower than in 2018-2021.

still counting1990200020102020
grewheldshrank

The same series as a ribbon: one cell per year, darker for more. The line above answers how much; this answers when.

Its share of all research

Growing output can still be a shrinking share: all of science grows. This is PCI Biotech (Norway) as a percentage of every work published that year, 0.0000036% in 2024.

still counting0.00020%0.00040%PCI Biotech (Norway)0.000031% in 20251990200020102020

Fractional works of PCI Biotech (Norway) over all fractional works that year. How the balance of science has shifted.

Other research institutions in Lysaker

All research institutions in Lysaker

Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners have tabs of their own, above.

Discussion

Ask a question or share a note about PCI Biotech (Norway). Posts are plain text and can be reported.